Table 2.

Needs and capabilities of electronic health records being used in outpatient post-transplant care (n=80)

	Number of respondents	Number (%) responded ‘Yes’
Does your liver program have a general guideline regarding pre-specified ranges for desired immunosuppressant drug levels for most patients?	79	73 (92%)
If “Yes”:
• Do pre-specified ranges change based on time since transplant?	70	65 (93%)
• Do pre-specified ranges change based on the presence of co-morbid conditions?	70	61 (87%)
• Are there other factors that determine the pre-specified ranges?	70	46 (67%)
Is a computer-generated alert received when an immunosuppressant lab result is outside the desired range?	77	21 (27%)
Does your liver program have a general guideline regarding pre-specified routine lab testing schedules for most patients?	79	77 (97%)
If “Yes”:
• Do pre-specified lab testing schedules change based on time since transplant?	75	73 (97%)
• Do pre-specified lab testing schedules change based on the presence of co-morbid conditions?	74	59 (80%)
• Are there other factors that determine the pre-specified lab testing schedules?	72	42 (58%)
Is a computer-generated alert received when an immunosuppressant lab result is overdue or missing?	75	15 (20%)
Is a computer-generated alert received when an immunosuppressant lab result is newly available?	77	42 (55%)
Does your electronic medical record system have the capability of graphing immunosuppressant drug levels from external labs?	78	33 (42%)
What is the status of graphing the following parameters in your electronic medical record system?
• Lab results of creatinine	73	64 (88%)
• Lab results of liver function tests	73	64 (88%)
• Lab results of immunosuppressant drug levels	72	59 (82%)
• Prescribed dose of immunosuppressants	73	44 (60%)
• Both the prescribed dose and lab results of immunosuppressant drug levels in the same graph	72	30 (42%)